| Primary |
| Hiv Infection |
52.7% |
| Acquired Immunodeficiency Syndrome |
11.4% |
| Antiretroviral Therapy |
7.3% |
| Antiviral Treatment |
5.5% |
| Drug Use For Unknown Indication |
4.6% |
| Product Used For Unknown Indication |
3.3% |
| Antifungal Prophylaxis |
3.2% |
| Diabetes Mellitus |
1.6% |
| Pain |
1.4% |
| Opportunistic Infection Prophylaxis |
1.2% |
| Hypertension |
1.2% |
| Infection Prophylaxis |
1.1% |
| Eosinophilic Pustular Folliculitis |
0.8% |
| Prophylaxis |
0.8% |
| Depression |
0.7% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Panic Disorder |
0.7% |
| Insomnia |
0.7% |
| Cerebral Toxoplasmosis |
0.5% |
| Syphilis |
0.5% |
|
| Vomiting |
14.6% |
| Rash |
13.2% |
| Drug Exposure During Pregnancy |
10.8% |
| Pyrexia |
7.0% |
| Myocardial Infarction |
6.6% |
| Renal Impairment |
5.9% |
| Hypersensitivity |
5.6% |
| Nausea |
3.8% |
| Maternal Exposure During Pregnancy |
3.5% |
| Rash Generalised |
3.5% |
| Stillbirth |
3.5% |
| Exposure During Pregnancy |
3.1% |
| Streptococcal Infection |
3.1% |
| Small For Dates Baby |
2.8% |
| Weight Decreased |
2.8% |
| Abortion Spontaneous |
2.1% |
| Death |
2.1% |
| Paralysis |
2.1% |
| Trisomy 21 |
2.1% |
| Dyspnoea |
1.7% |
|
| Secondary |
| Hiv Infection |
57.8% |
| Drug Exposure During Pregnancy |
5.6% |
| Antiretroviral Therapy |
5.5% |
| Drug Use For Unknown Indication |
5.5% |
| Acquired Immunodeficiency Syndrome |
4.6% |
| Hypertension |
3.0% |
| Product Used For Unknown Indication |
2.8% |
| Diabetes Mellitus |
2.2% |
| Maternal Exposure Timing Unspecified |
2.2% |
| Pneumocystis Jiroveci Infection |
1.5% |
| Antiviral Treatment |
1.2% |
| Opportunistic Infection Prophylaxis |
1.1% |
| Encephalitis Cytomegalovirus |
1.1% |
| Maternal Exposure During Pregnancy |
1.0% |
| Factor Viii Deficiency |
0.9% |
| Prophylaxis |
0.9% |
| Mycobacterium Avium Complex Infection |
0.9% |
| Antifungal Prophylaxis |
0.8% |
| Oral Candidiasis |
0.8% |
| Gastritis |
0.6% |
|
| Pregnancy |
8.6% |
| Abortion Spontaneous |
6.9% |
| Stillbirth |
6.9% |
| Drug Exposure During Pregnancy |
6.5% |
| Normal Newborn |
6.5% |
| Rash |
6.5% |
| Vomiting |
6.5% |
| Vitamin B12 Deficiency |
5.2% |
| Trisomy 21 |
4.7% |
| Uveitis |
4.7% |
| Laboratory Test Abnormal |
4.3% |
| Small For Dates Baby |
4.3% |
| Pancytopenia |
3.9% |
| Weight Increased |
3.9% |
| Hypersensitivity |
3.4% |
| Liver Disorder |
3.4% |
| Microcephaly |
3.4% |
| Pyrexia |
3.4% |
| Renal Disorder |
3.4% |
| Renal Impairment |
3.4% |
|
| Concomitant |
| Hiv Infection |
58.4% |
| Product Used For Unknown Indication |
7.5% |
| Drug Use For Unknown Indication |
5.2% |
| Acquired Immunodeficiency Syndrome |
4.7% |
| Mycobacterium Avium Complex Infection |
3.2% |
| Hepatitis C |
2.5% |
| Prophylaxis |
1.9% |
| Antifungal Prophylaxis |
1.7% |
| Hypertension |
1.7% |
| Maternal Exposure Timing Unspecified |
1.5% |
| Diabetes Mellitus |
1.5% |
| Kaposi's Sarcoma Aids Related |
1.4% |
| Depression |
1.3% |
| Cytomegalovirus Chorioretinitis |
1.3% |
| Antiviral Treatment |
1.2% |
| Hyperlipidaemia |
1.2% |
| Neuropathy Peripheral |
1.1% |
| Hiv Test Positive |
1.0% |
| Pain |
1.0% |
| Pneumocystis Jiroveci Pneumonia |
0.9% |
|
| Vomiting |
8.9% |
| Abortion Spontaneous |
7.3% |
| Death |
7.3% |
| Renal Failure Acute |
7.3% |
| Weight Decreased |
7.3% |
| Myocardial Infarction |
5.7% |
| Rash |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Abortion Induced |
5.2% |
| Premature Baby |
4.2% |
| Suicide Attempt |
4.2% |
| Visual Field Defect |
4.2% |
| Depression |
3.6% |
| Pneumonia |
3.6% |
| Renal Failure |
3.6% |
| Renal Impairment |
3.6% |
| Drug Ineffective |
3.1% |
| Fatigue |
3.1% |
| Pancytopenia |
3.1% |
| Thrombocytopenia |
3.1% |
|
| Interacting |
| Hiv Infection |
75.0% |
| Bipolar Disorder |
25.0% |
|
|
